External Validation of VVI (E-VVI)

February 8, 2026 updated by: DEMOSTHENES MAKRIS, University of Thessaly

External Validation of the Volume-Velocity Index for Weaning Prediction: a Multicenter Observational Study

Failure of liberation from mechanical ventilation increases days spent being mechanically ventilated, the length of stay and the morbidity of patients. Thus it is crucial that those patients who are ready to be liberated are accurately detected. In this study the investigators want to externally validate an index (the volume-velocity index, VVI) which in a preliminary study was found to predict with high accuracy the outcome of ventilator liberation.

In this study, in patients who are deemed ready to undergo weaning by their treating physician the investigators will measure the excursion of the diaphragm, the principal respiratory muscle, the inspiratory time and the tidal volume and the volume breathed by the patient at each respiration in three phases:

  1. during pressure support ventilation with 5/5,
  2. during pressure support ventilation with 8/0,
  3. during t-tube or pressure support ventilation with 0/0. All of these phases are ventilatory modalities widely used during weaning from mechanical ventilation.

The investigators will evaluate whether VVI can predict accurately the weaning outcome.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Larissa, Greece, 41110
        • Recruiting
        • General University Hospital Of Larissa
        • Contact:
        • Principal Investigator:
          • Apostolos Alkiviadis Menis
      • Thessaloniki, Greece, 57010
        • Not yet recruiting
        • General Hospital of Thessaloniki "G. Papanikolaou"
        • Contact:
        • Principal Investigator:
          • Christos Karachristos
      • Thessaloniki, Greece, 54636
        • Not yet recruiting
        • AHEPA - University General Hospital
        • Contact:
        • Principal Investigator:
          • Anna Gkiouliava

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Critical Care patients undergoing weaning from mechanical ventilation

Description

Inclusion Criteria:

  • Mechanically ventilated patients for more than 48h
  • First Spontaneous breathing trial
  • Deemed as ready to undergo weaning by the treating physician, according to published readiness criteria (DOI: 10.1183/09031936.00010206)

Exclusion Criteria:

  • pregnant patients
  • preexisting diaphragmatic disease or injury
  • tracheostomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients undergoing weaning

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weaning outcome
Time Frame: From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.
Validate the predictive capability of VVI for weaning outcome
From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VVI for SBT or extubation
Time Frame: From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.
Comparison of the capability of VVI to predict SBT or extubation failure
From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
VVI vs RSBI
Time Frame: From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.
Comparison of the predictive capability of VVI with RSBI for weaning outcome
From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.
Predictive capability of VVI between long or short ventilation time
Time Frame: From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.
Comparison of the redictive capability of VVI between patients ventilated for more than 7 days with patients ventilated for less than 7 days
From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.
VVI in various SBT modalities
Time Frame: From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.
Compare the ability of VVI to predict the weaning outcome in various SBT modalities, namely Pressure Support 8/0 and Pressure Support 5/5 versus t-tube or Pressure Support 0/0
From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.
Relationship of VVI with MIP and MRC
Time Frame: From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.
evaluate the relationship of VVI with indices of strength status such as the maximal inspiratory pressure, for the respiratory muscles, and the medical research council score, for the ICU acquired weakness.
From the start of the spontaneous breathing trial to failure or success at 48 hours after exubation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Apostolos - Alkiviadis Menis, General University Hospital Of Larissa
  • Study Director: Demosthenes Makris, University of Thessaly

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 28, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

January 19, 2026

First Submitted That Met QC Criteria

January 19, 2026

First Posted (Actual)

January 28, 2026

Study Record Updates

Last Update Posted (Actual)

February 11, 2026

Last Update Submitted That Met QC Criteria

February 8, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 23/17/16-12-25

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weaning Mechanical Ventilation

Subscribe